Shandong Weigao Medical Polymer Total Assets 2012-2024 | SHWGF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Shandong Weigao Medical Polymer total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Shandong Weigao Medical Polymer total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$204.2B
Stryker (SYK)	$146.7B
Boston Scientific (BSX)	$132.6B
EssilorLuxottica (ESLOY)	$112.1B
Medtronic (MDT)	$110.6B
Haleon (HLN)	$43.7B
Lonza Group Ag (LZAGY)	$42.2B
GE HealthCare Technologies (GEHC)	$37.7B
ResMed (RMD)	$35.8B
Terumo (TRUMY)	$29.7B
Koninklijke Philips (PHG)	$24.8B
Zimmer Biomet Holdings (ZBH)	$21.9B
Insulet (PODD)	$18.4B
Baxter (BAX)	$17B
Smith & Nephew SNATS (SNN)	$11.1B
BellRing Brands (BRBR)	$10.2B
Bio-Rad Laboratories (BIO)	$9.3B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.3B
TG Therapeutics (TGTX)	$5.5B
Haemonetics (HAE)	$4.3B
Prestige Consumer Healthcare (PBH)	$4.2B
ICU Medical (ICUI)	$4.1B
Perrigo (PRGO)	$3.8B
Envista Holdings (NVST)	$3.7B
Neogen (NEOG)	$3.2B
Agios Pharmaceuticals (AGIO)	$3.2B
GN Store Nord (GNNDY)	$2.8B
QuidelOrtho (QDEL)	$2.7B
LeMaitre Vascular (LMAT)	$2.4B